T. Kubota et al., IDENTIFICATION OF 2 NOVEL MUTATIONS IN THE OCRL1 GENE IN JAPANESE FAMILIES WITH LOWE-SYNDROME, Clinical genetics, 54(3), 1998, pp. 199-202
The oculocerebrorenal syndrome of Lowe (OCRL) is a rare X-linked disor
der with features of congenital cataracts, Fanconi syndrome of the ren
al tubule, and mental retardation. The OCRL1 gene has been positionall
y cloned and shown to encode a phosphatidylinositol 4,5-biphosphate-5-
phosphatase. OCRL is thus thought to be an inborn err-or of inositol p
olyphosphate metabolism. We analyzed the gene in two Japanese OCRL pat
ients and their families by DNA sequencing and mismatch polymerase cha
in reaction (PCR) followed by restriction digestion. A novel nonsense
mutation (C1399T) replacing the glutamine of codon 391 (Gln 391 Stop)
was identified in exon 12 in 1 patient and also in his mother. A novel
missense mutation (C1743G) was identified in exon 15 in the second pa
tient, his mother and maternal grandmother, The missense mutation pred
icts a substitution of serine for arginine (Ser 505 Arg) in a domain h
ighly conserved among the inositol-5-phosphatase family. Our observati
ons expand the range of OCRL1 mutations that cause Lowe syndrome, and
will be useful for genetic counseling in these two families.